Bio4Dreams

Euleria is a company specializing in digital rehabilitation devices and patient recovery solutions. It develops innovative medical technologies that facilitate rehabilitation both on-site and remotely. The company's platform offers exercise therapy tailored for patients undergoing rehabilitation, allowing them to complete programs in various settings, including clinics and their homes. Euleria also provides an online portal for patients to connect with professionals, enabling movement specialists to monitor progress and support individuals throughout their healing journey. By focusing on measurable and accessible rehabilitation, Euleria aims to enhance the recovery experience for both patients and healthcare providers.

BrainDTech is a company focused on the early diagnosis and monitoring of neurological and neurodegenerative diseases through innovative liquid biopsy technology. Utilizing a patented method, the company analyzes miRNA derived from microglial microvesicles to provide accurate diagnosis, prognosis, and treatment monitoring for various brain conditions. This platform allows healthcare professionals to predict the onset of brain diseases before symptoms manifest, enhancing the potential for timely intervention and improved patient outcomes. By concentrating on both neurodegenerative and inflammatory diseases, BrainDTech aims to advance the field of neurology with its cutting-edge diagnostic solutions.

BrainDTech is a company focused on the early diagnosis and monitoring of neurological and neurodegenerative diseases through innovative liquid biopsy technology. Utilizing a patented method, the company analyzes miRNA derived from microglial microvesicles to provide accurate diagnosis, prognosis, and treatment monitoring for various brain conditions. This platform allows healthcare professionals to predict the onset of brain diseases before symptoms manifest, enhancing the potential for timely intervention and improved patient outcomes. By concentrating on both neurodegenerative and inflammatory diseases, BrainDTech aims to advance the field of neurology with its cutting-edge diagnostic solutions.

BrainDTech is a company focused on the early diagnosis and monitoring of neurological and neurodegenerative diseases through innovative liquid biopsy technology. Utilizing a patented method, the company analyzes miRNA derived from microglial microvesicles to provide accurate diagnosis, prognosis, and treatment monitoring for various brain conditions. This platform allows healthcare professionals to predict the onset of brain diseases before symptoms manifest, enhancing the potential for timely intervention and improved patient outcomes. By concentrating on both neurodegenerative and inflammatory diseases, BrainDTech aims to advance the field of neurology with its cutting-edge diagnostic solutions.